Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy

Stephen Lynn, Annemieke Aartsma-Rus, Kate Bushby, Pat Furlong, Nathalie Goemans, Annamaria De Luca, Anna Mayhew, Craig M McDonald, Eugenio Mercuri, Francesco Muntoni, Marita Pohlschmidt, Jan Verschuuren, Thomas Voit, Elizabeth Vroom, Dominic J. Wells, Volker Straub

Research output: Contribution to journalArticle

32 Scopus citations
Original languageEnglish (US)
Pages (from-to)96-105
Number of pages10
JournalNeuromuscular Disorders
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)
  • Neurology

Cite this

Lynn, S., Aartsma-Rus, A., Bushby, K., Furlong, P., Goemans, N., De Luca, A., Mayhew, A., McDonald, C. M., Mercuri, E., Muntoni, F., Pohlschmidt, M., Verschuuren, J., Voit, T., Vroom, E., Wells, D. J., & Straub, V. (2015). Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy. Neuromuscular Disorders, 25(1), 96-105. https://doi.org/10.1016/j.nmd.2014.09.003